THE GALA PEPTIDE: MULTIPLE ROLES IN DRUG AND GENE DELIVERY | ||||
| Bulletin of Pharmaceutical Sciences Assiut University | ||||
| Article 4, Volume 43, Issue 1, June 2020, Page 39-51 PDF (745.57 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bfsa.2020.93573 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Ikramy A. Khalil1; Hideyoshi Harashima2 | ||||
| 1Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt | ||||
| 2Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan | ||||
| Abstract | ||||
| Therapeutic nucleic acids must be formulated in delivery systems that permit them to be efficiently targeted to specific tissues within the body and to overcome the endosomal barrier to deliver these molecules to their intracellular target sites. GALA is a synthetic amphipathic 30 amino acids peptide that performs both functions. It has the ability to target the lung endothelium and induce membrane fusion, which facilitates endosomal escape of therapeutic nucleic acids. In this review, we introduce the GALA peptide and discuss its multiple roles in drug and gene delivery. We first describe the peptide and its ability to induce membrane fusion and pore-formation. We next focus on applications of this peptide in gene delivery in-vitro and in-vivo. We also discuss the synergistic combination between GALA and oligoargnine peptides and their applicability to active tumor targeting. The GALA peptide introduced in this review has great promise as an efficient tool for gene delivery. | ||||
|
Statistics Article View: 351 PDF Download: 488 |
||||
